60. IDEAL TREATMENT REGIMEN FOR PATIENTS WITH ≥1 BRAIN METASTASIS FROM PRIMARY NON-SMALL-CELL LUNG CANCER – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

BACKGROUND: Brain metastases (BM) are common in non-small cell lung cancer (NSCLC). The aim of this study was to assess the comparative effectiveness of treatments for BM from NSCLC. METHODS: We searched MEDLINE, EMBASE, Web of Science, ClinicalTrials.gov, CENTRAL and references of key studies for r...

Descripción completa

Detalles Bibliográficos
Autores principales: Brar, Karanbir, Ellenbogen, Yosef, Sadeghirad, Behnam, Deng, Jiawen, Hou, Winston, Wang, Xiaoqin, Taslimi, Shervin, Mansouri, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401406/
http://dx.doi.org/10.1093/noajnl/vdaa073.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401406/
http://dx.doi.org/10.1093/noajnl/vdaa073.048

Ejemplares similares